Published in Nutrients on June 01, 2016
Bioenergetics and Metabolism in Pediatric Populations | NCT03323294
The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answers. Chin J Cancer (2017) 1.33
Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation. Front Microbiol (2017) 0.77
Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and Diseases. Visc Med (2016) 0.75
A Cutoff for Age at Menarche Predicting Metabolic Syndrome in Egyptian Overweight/Obese Premenopausal Women. Diabetes Metab J (2017) 0.75
Surgical Treatment of Metabolic Syndrome. Visc Med (2016) 0.75
Metabolomics allow the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children. Int J Obes (Lond) (2017) 0.75
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med (2008) 9.95
Dynamics of fat cell turnover in humans. Nature (2008) 9.80
Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med (2013) 9.66
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Identification and characterization of metabolically benign obesity in humans. Arch Intern Med (2008) 5.74
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab (2006) 5.33
Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation (2009) 4.78
Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab (2012) 3.26
The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab (2005) 3.21
What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab (2001) 3.11
The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J (2012) 3.02
The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol (2010) 2.90
Are there persons who are obese, but metabolically healthy? Metabolism (2001) 2.80
The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72
Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia (2008) 2.64
Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes (2009) 2.60
Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56
Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care (2010) 2.42
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov (2010) 2.14
The obese healthy paradox: is inflammation the answer? Biochem J (2010) 2.14
Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes (2009) 2.11
Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care (2005) 1.99
Metabolically healthy but obese individuals. Lancet (2008) 1.91
Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis (2011) 1.89
High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab (2008) 1.76
It's not how fat you are, it's what you do with it that counts. PLoS Biol (2008) 1.69
Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab (2013) 1.67
The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord (2014) 1.64
Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol (2007) 1.52
From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis (2009) 1.49
Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) (2011) 1.45
Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab (2013) 1.41
Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes (1999) 1.40
The metabolic syndrome and inflammation. Metab Syndr Relat Disord (2004) 1.37
Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition (2012) 1.33
Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J (2014) 1.32
Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review. BMC Public Health (2014) 1.31
Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One (2013) 1.30
Benefits of the Mediterranean Diet: Insights From the PREDIMED Study. Prog Cardiovasc Dis (2015) 1.23
Effects of weight loss among metabolically healthy obese men and women. Diabetes Care (2010) 1.22
Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes (2008) 1.16
Fat cell turnover in humans. Biochem Biophys Res Commun (2010) 1.15
Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia (2010) 1.14
Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health (2011) 1.14
Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J (2009) 1.13
Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis (2009) 1.13
The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) (2009) 1.12
The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring) (2010) 1.10
Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One (2011) 1.10
Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol (2012) 1.02
Leisure time and occupational physical activity in relation to obesity and insulin resistance: a population-based study from the Skaraborg Project in Sweden. Metabolism (2011) 1.02
Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obes (Lond) (2015) 1.00
Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J (2011) 1.00
Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. Am J Epidemiol (2012) 1.00
IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology (2010) 0.99
Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. Biomed Res Int (2013) 0.96
Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter? Metabolism (2014) 0.96
Intensive lifestyle intervention improves cardiometabolic and exercise parameters in metabolically healthy obese and metabolically unhealthy obese individuals. Can J Cardiol (2013) 0.95
Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism (2013) 0.92
Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int J Obes (Lond) (2013) 0.90
Obesity phenotype and cardiovascular changes. J Hypertens (2011) 0.90
From metabolic normality to cardiometabolic risk factors in subjects with obesity. Obesity (Silver Spring) (2012) 0.87
Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration. Diabetes Care (2012) 0.85
Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study. Int J Obes (Lond) (2014) 0.85
Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function. Diabetes (2014) 0.83
A metabolically healthy obese phenotype in hispanic participants in the IRAS family study. Obesity (Silver Spring) (2013) 0.80
Obesity: Can inflammatory status define metabolic health? Nat Rev Endocrinol (2013) 0.79
Who should we target for diabetes prevention and diabetes risk reduction? Curr Diab Rep (2012) 0.79